Outcomes of buprenorphine maintenance in office-based practice

被引:28
|
作者
Magura, Stephen
Lee, Stephen J.
Salsitz, Edwin A.
Kolodny, Andrew
Whitley, Susan D.
Taubes, Tanaquil
Seewald, Randy
Joseph, Herman
Kayman, Deborah J.
Fong, Chunki
Marsch, Lisa A.
Rosenblum, Andrew
机构
[1] Natl Dev & Res Inst Inc, New York, NY 10010 USA
[2] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA
[3] Albert Einstein Med Ctr, Philadelphia, PA 19141 USA
关键词
buprenorphine; opioids; substance misuse; office-based treatment; drug dependence treatment; OPIOID DEPENDENCE; PSYCHIATRIC-DIAGNOSIS; HEROIN DEPENDENCE; CONTROLLED TRIAL; OPIATE ADDICTS; METHADONE; COMORBIDITY; ABUSE;
D O I
10.1300/J069v26n02_03
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Buprenorphine is an efficacious treatment for opioid dependence recently approved for office-based medical practice. The purpose of the study was to describe the background characteristics, treatment process, outcomes and correlates of outcomes for patients receiving buprenorphine maintenance in "real world" office-based settings in New York City, without employing the many patient exclusion criteria characterizing clinical research studies of buprenorphine, including absence of co-occurring psychiatric and non-opioid substance use disorders. A convenience sample of six physicians completed anonymous chart abstraction forms for all patients who began buprenorphine induction or who transferred to these practices during 2003-2005 (N = 86). The endpoint was the patient's current status or status at discharge from the index practice, presented in an intent-to-treat analysis. The results were: male (74%); median age (38 yrs); White, non-Hispanic (82%); employed full-time, (58%); HCV+ (15%); substance use at intake: prescription opioids (50%), heroin (35%), non-opioids (49%); median length of treatment (8 months); median maintenance dose (15 mg/day); prescribed psychiatric medication (63%). The most frequent psychiatric disorders were: major depression, obsessive-compulsive and other anxiety, bipolar. At the endpoint: retained in the index practice (55%); transferred to other buprenorphine practice (6%); transferred to other treatment (7%); lost to contact or out of any treatment (32%). Outcomes were positive, in that 2/3 of patients remained in the index practice or transferred to other treatment. Patients living in their own home or misusing prescription opioids (rather than heroin) were more likely, and those employed part-time were less likely, to be retained in the index practice. At the endpoint, 24% of patients were misusing drugs or alcohol. Co-occurring psychiatric disorders and polysubstance abuse at intake were common, but received clinical attention, which may explain why their effect on outcomes was minimal.
引用
收藏
页码:13 / 23
页数:11
相关论文
共 50 条
  • [41] Office-Based Anesthesia: Safety and Outcomes
    Shapiro, Fred E.
    Punwan, Nathan
    Rosenberg, Noah M.
    Valedon, Arnaldo
    Twersky, Rebecca
    Urman, Richard D.
    ANESTHESIA AND ANALGESIA, 2014, 119 (02): : 276 - 285
  • [42] Criminal Charges Prior to and After Enrollment in Opioid Agonist Treatment: A Comparison of Methadone Maintenance and Office-based Buprenorphine
    Rastegar, Darius A.
    Kawasaki, Sarah Sharfstein
    King, Van L.
    Harris, Elizabeth E.
    Brooner, Robert K.
    SUBSTANCE USE & MISUSE, 2016, 51 (07) : 803 - 811
  • [43] Office-based ambulatory anesthesia: Outcomes of clinical practice of oral and maxillofacial surgeons
    Perrott, DH
    Yuen, JP
    Andresen, RV
    Dodson, TB
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2003, 61 (09) : 983 - 995
  • [44] Smoking cessation treatment among office-based buprenorphine treatment patients
    Nahvi, Shadi
    Blackstock, Oni
    Sohler, Nancy L.
    Thompson, Devin
    Cunningham, Chinazo O.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2014, 47 (02) : 175 - 179
  • [45] Risk of osteoporosis in an office-based neurological practice
    Janus, EJ
    Janus, TJ
    NEUROLOGY, 2004, 62 (07) : A218 - A219
  • [46] Criminal charges prior to and after initiation of office-based buprenorphine treatment
    Elizabeth E Harris
    Janet Soeffing Jacapraro
    Darius A Rastegar
    Substance Abuse Treatment, Prevention, and Policy, 7
  • [47] Practice management issues in office-based anesthesiology
    Galati, Maria
    TECHNIQUES IN GASTROINTESTINAL ENDOSCOPY, 2009, 11 (04) : 202 - 209
  • [48] Office-based bronchoscopy - Ready for your practice?
    Lunn, William W.
    CHEST, 2006, 130 (06) : 1900 - 1905
  • [49] Randomized pilot trial of Web-based cognitive-behavioral therapy adapted for use in office-based buprenorphine maintenance
    Shi, Julia M.
    Henry, Susan P.
    Dwy, Stephanie L.
    Orazietti, Skye A.
    Carroll, Kathleen M.
    SUBSTANCE ABUSE, 2019, 40 (02) : 132 - 135
  • [50] Criminal charges prior to and after initiation of office-based buprenorphine treatment
    Harris, Elizabeth E.
    Jacapraro, Janet Soeffing
    Rastegar, Darius A.
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2012, 7